Hitesha Trivedi
First author of a 2026 PRISMA-guided systematic review of senolytic, senomorphic and anti-ageing drug trials in humans.
Department of Pharmacology, Zydus Medical College and Hospital · Dahod, India
Hitesha Trivedi is in the Department of Pharmacology at Zydus Medical College and Hospital in Dahod, India. In 2026 she led a PRISMA 2020 systematic review that pulled together every completed human clinical trial testing drugs meant to clear or calm senescent cells — senolytics such as dasatinib plus quercetin, alongside senomorphic and mTOR-targeting approaches — and judged the evidence against ageing to be real but still thin.
Milestones in the Atlas
A selection, not a full bibliography: only papers that meet the Atlas inclusion criteria.
| Year | Evidence | Study |
|---|---|---|
| 2026 | S | Therapeutic reversal of cellular senescence: A systematic review of senolytics, senomorphics and anti-ageing therapies in human clinical trials TRI2026 Led the systematic review of senolytic, senomorphic and mTOR-targeting human trials. |
Co-authors in the Atlas
People with a profile here who share at least one study with Hitesha Trivedi.
- Sohel Shaikh Senior author of the same 2026 systematic review of senolytic and anti-ageing drug trials in humans.
Every researcher with a profile →
Thank you. Your answer was counted anonymously.
Thank you. That helps us know which pages have been read by someone who knows the work.
Thank you. We will check it and correct the page.